Nexus AG
XETRA:NXU
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
47.15
69.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Nexus AG
Nexus AG
Cash & Cash Equivalents
Nexus AG
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nexus AG
XETRA:NXU
|
Cash & Cash Equivalents
€17.5m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
0%
|
|
|
CompuGroup Medical SE & Co KgaA
XETRA:COP
|
Cash & Cash Equivalents
€77.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
13%
|
CAGR 10-Years
21%
|
|
|
DocCheck AG
XETRA:AJ91
|
Cash & Cash Equivalents
€14.4m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
CHAPTERS Group AG
XETRA:CHG
|
Cash & Cash Equivalents
€50.8m
|
CAGR 3-Years
336%
|
CAGR 5-Years
113%
|
CAGR 10-Years
N/A
|
|
Nexus AG
Glance View
Nexus AG, a prominent figure in the healthcare IT sector, has carved a niche for itself by specializing in software solutions that enhance the operational efficiency and care quality of hospitals and healthcare institutions. Founded with a vision to bridge the gap between innovative technology and healthcare services, Nexus AG crafts integrated software platforms that streamline hospital workflows, from patient admission to billing processes. This not only helps healthcare providers improve service delivery but also allows for smoother regulatory compliance and administrative management. By understanding the unique challenges faced by healthcare professionals, Nexus AG has positioned itself as an indispensable partner to over a thousand hospitals across Europe and beyond. The revenue model of Nexus AG hinges on the strategic deployment of its software solutions, combining upfront licensing fees with ongoing maintenance and support contracts. This ensures a steady stream of recurring revenue, bolstered by consultancy services and tailored modifications that meet client-specific needs. The company continuously invests in research and development to keep its offerings cutting-edge, while also exploring expansion opportunities in adjacent markets and technologies. By fostering long-term relationships with its clients, Nexus AG transforms technological advancement into tangible solutions that provide efficiency and cost savings for the healthcare sector, sustaining its growth and relevance in an ever-evolving market.
See Also
What is Nexus AG's Cash & Cash Equivalents?
Cash & Cash Equivalents
17.5m
EUR
Based on the financial report for Sep 30, 2024, Nexus AG's Cash & Cash Equivalents amounts to 17.5m EUR.
What is Nexus AG's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
0%
Over the last year, the Cash & Cash Equivalents growth was 48%. The average annual Cash & Cash Equivalents growth rates for Nexus AG have been -10% over the past three years , -11% over the past five years .
You don't have any saved screeners yet
